---
schema_version: "secwatch.filing_event.v1"
accession: "0001100682-22-000002"
form_type: "8-K"
ticker: "CRL"
cik: "0001100682"
company_name: "CHARLES RIVER LABORATORIES INTERNATIONAL, INC."
filed_at: "2022-01-11T23:59:59+00:00"
generated_at: "2026-06-27T18:50:30.270453+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "medium"
source: SEC EDGAR
---

# Charles River Labs CFO David Smith to retire; provides preliminary 2022 guidance

## Summary
- CFO David R. Smith will retire; he will remain until a successor is named, expected by end of 2022.
- At J.P. Morgan Healthcare Conference, management presented preliminary 2022 outlook for revenue growth, organic revenue growth, non-GAAP operating margin, non-GAAP EPS, free cash flow, and capex.
- Specific numerical guidance was not included in the filing; slide deck is available on the company's IR website.

## SEC filing metadata
- accession: 0001100682-22-000002
- form_type: 8-K
- ticker: CRL
- cik: 0001100682
- company_name: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- filed_at: 2022-01-11T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: medium
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1100682/000110068222000002/0001100682-22-000002-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1100682/000110068222000002/crl-20220111.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001100682-22-000002
- JSON: https://secwatch.observer/filing/0001100682-22-000002.json
- Plain text: https://secwatch.observer/filing/0001100682-22-000002.txt

## Key facts
- Executive change
  David R. Smith departed as Corporate Executive Vice President and Chief Financial Officer at CHARLES RIVER LABORATORIES INTERNATIONAL, INC..
  - Action: retire
  - Role: Corporate Executive Vice President and Chief Financial Officer
  source text: On January 11, 2022, Charles River Laboratories International, Inc. (the “Company”) announced that David R. Smith, its Corporate Executive Vice President and Chief Financial Officer, will retire from the Company after a distinguished career in healthcare and finance leadership roles.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1100682/000110068222000002/0001100682-22-000002-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.